About Epoprostenol
            
            Class: | Prostacyclin analog  
Use: | Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and prolong survival  
Adult dose: | Initial: 2 ng/kg/min IV continuous infusion; may be increased by 1-2 ng/kg/min every 15 minutes as tolerated, up to a maximum of 40 ng/kg/min  
Pediatric dose: | Not established; use in pediatric patients should be based on clinical judgment and individual patient needs  
Side effects: | Headache, flushing, hypotension, nausea, diarrhea, jaw p
         
        
            
                
                
                    
                        Drug Class
                    
                    Prostacyclin analog
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and prolong survival
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator (2°C to 8°C or 36°F to 46°F); protect from light; once reconstituted, use immediately or store at room temperature for up to 24 hours
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: GlaxoSmithKline Australia Pty Ltd, Australia
                    
                    
                    Package Size
                    1 Vial (Powder) + 2 Diluent Vial (50ml)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 368.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial: 2 ng/kg/min IV continuous infusion; may be increased by 1-2 ng/kg/min every 15 minutes as tolerated, up to a maximum of 40 ng/kg/min
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; use in pediatric patients should be based on clinical judgment and individual patient needs
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, flushing, hypotension, nausea, diarrhea, jaw pain, and infusion site reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to epoprostenol or any component of the formulation; severe pulmonary hemorrhage; and patients with certain cardiovascular conditions that may be exacerbated by vasodilation
         
        
        
            
                Important Warnings
            
            Risk of rebound pulmonary hypertension upon abrupt discontinuation; caution in patients with bleeding disorders or those on anticoagulant therapy; monitor for signs of infection at the infusion site and systemic effects of vasodilation
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.